These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15542408)

  • 1. C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy.
    Sliwa K; Woodiwiss A; Libhaber E; Zhanje F; Libhaber C; Motara R; Essop R
    Eur J Heart Fail; 2004 Oct; 6(6):731-4. PubMed ID: 15542408
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.
    Bahrmann P; Hengst UM; Richartz BM; Figulla HR
    Eur J Heart Fail; 2004 Mar; 6(2):195-201. PubMed ID: 14984727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.
    Sliwa K; Skudicky D; Candy G; Wisenbaugh T; Sareli P
    Lancet; 1998 Apr; 351(9109):1091-3. PubMed ID: 9660578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].
    Latini R
    Ital Heart J Suppl; 2001 Jun; 2(6):692-3. PubMed ID: 11460849
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.
    Sliwa K; Woodiwiss A; Kone VN; Candy G; Badenhorst D; Norton G; Zambakides C; Peters F; Essop R
    Circulation; 2004 Feb; 109(6):750-5. PubMed ID: 14970111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Sliwa K; Woodiwiss A; Candy G; Badenhorst D; Libhaber C; Norton G; Skudicky D; Sareli P
    Am J Cardiol; 2002 Nov; 90(10):1118-22. PubMed ID: 12423714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.
    Skudicky D; Sliwa K; Bergemann A; Candy G; Sareli P
    Heart; 2000 Oct; 84(4):438-9. PubMed ID: 10995419
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive value of high-sensitivity C-reactive protein in patients with idiopathic dilated cardiomyopathy.
    Lamparter S; Grimm W
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S233-6. PubMed ID: 15683503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Akatsu T; Shimoda Y; Segawa I; Hiramori K
    Eur J Heart Fail; 2005 Aug; 7(5):748-54. PubMed ID: 16087131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
    Selim K; Hüseyin C; Ibrahim KH; Hasan BU; Kazim U; Hüseyin K
    Med J Malaysia; 2004 Aug; 59(3):391-4. PubMed ID: 15727386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine-mediated attenuation of the innate immune response for only those who need it? The tailored potential of pentoxifylline.
    Ramakers BP; Pickkers P
    Shock; 2010 Jul; 34(1):105-6. PubMed ID: 20016402
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-term statin therapy and cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
    van der Harst P; Voors AA; van Veldhuisen DJ
    Circulation; 2004 Feb; 109(5):e34; author reply e34. PubMed ID: 14769695
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Scheuer J
    Circulation; 2009 Mar; 119(11):e371; author reply e372. PubMed ID: 19307483
    [No Abstract]   [Full Text] [Related]  

  • 16. Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-alpha production in rat mesangial cell cultures.
    Leithäuser ML; Rob PM; Sack K
    Exp Nephrol; 1997; 5(1):100-4. PubMed ID: 9052855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.
    Mocelin AO; Issa VS; Bacal F; Guimarães GV; Cunha E; Bocchi EA
    Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological mechanisms of pentoxifylline in chronic heart failure.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Eur J Heart Fail; 2009 Jul; 11(7):728. PubMed ID: 19457899
    [No Abstract]   [Full Text] [Related]  

  • 19. Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event.
    Binkley PF; Lesinski A; Ferguson JP; Hatton PS; Yamokoski L; Hardikar S; Cooke GE; Leier CV
    Am Heart J; 2008 Jan; 155(1):69-74. PubMed ID: 18082492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.